
 Scientific claim: Differentiation of progenitor cells to myeloid cells is skewed upon activation of insulin signaling. 
 Participant Dynamics: Originator vs. Interpreter 
 Contextual Arena: The Didactic Arena (goal: to teach or learn) 
 Interaction Trigger: An External Mandate (a new law, policy, or trend) 
 Dialogue Objective: To Expose a Flaw or Truth (validate or weaken the claim) 
```
Dr. Thompson: So, according to the latest policy from the Health Research Council, all funded projects must now consider the potential effects of insulin signaling on myeloid cell differentiation. This is quite a shift, wouldn't you say?

Dr. Patel: Yes, indeed. The claim that insulin signaling skews progenitor cells' differentiation towards myeloid lineage has certainly stirred the pot. But, isn't this based on a single study? 

Dr. Thompson: Precisely. The study by Dr. Kim et al. They observed this skewing effect in vitro. However, the in vivo implications remain untested.

Dr. Patel: Exactly my point. We cannot make broad policy changes based on preliminary in vitro data. What about the variability in insulin signaling pathways across different organisms?

Dr. Thompson: That's a critical oversight. The signaling pathway's complexity and its interaction with other cellular processes were not fully explored in their research. 

Dr. Patel: And yet, here we are with a mandate affecting research directions. It almost feels like we're jumping the gun, doesn't it?

Dr. Thompson: It certainly raises concerns. The policy aims to preemptively guide research, but without robust supporting evidence, it risks steering us down a potentially misleading path.

Dr. Patel: Agreed. How do we address this in our research proposal? We need to acknowledge the claim but also highlight the need for more comprehensive studies.

Dr. Thompson: We should propose a dual approach: replicate the initial findings and conduct broader in vivo studies. That way, we can either validate or challenge the claim with a solid evidence base.

Dr. Patel: Sounds like a plan. Hopefully, the council will appreciate a more cautious and thorough approach. After all, science thrives on rigorous validation.

Dr. Thompson: Indeed, let's ensure our research remains grounded in evidence, not just trends or mandates.

```